Our achievements would not be possible without the outstanding team that make up Shield Therapeutics’ staff, management and board of directors.

Chief Medical Officer

Dr Mark Sampson

Appointed as VP, Medical Affairs at Shield in 2015 and transitioned into the role of CMO earlier this year, Mark joined us with more than 25 years of medical practice, pharmaceutical development and commercialisation experience. Mark brings to our team an outstanding pedigree in medical development and leadership at companies such as SmithKline Beecham, Amgen and Gilead, having been a key member of a number of successful commercialisation projects. Mark is a highly experienced pharmaceutical physician who combines broad medical knowledge and business acumen, with an impressive record of achievement at affiliate, regional and global levels across pharmaceutical, biotech and consumer products. In addition Mark was a member of the UK Prescription Medicines Code of Practice Appeals Board for 13 years.

Back to team